<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16559">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01813409</url>
  </required_header>
  <id_info>
    <org_study_id>ACR-RCR</org_study_id>
    <nct_id>NCT01813409</nct_id>
  </id_info>
  <brief_title>Rheumatology Clinical Registry</brief_title>
  <acronym>RCR</acronym>
  <official_title>American College of Rheumatology Clinical Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American College of Rheumatology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American College of Rheumatology</source>
  <oversight_info>
    <authority>United States: American College of Rheumatology</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ACR Rheumatology Clinical Registry (RCR) is a tool developed to assist members in
      practice improvement, local population management, and efficient, successful participation
      in national quality programs. RCR integrates evidence-based quality measures aimed at
      improving care and drug safety for patients with rheumatoid arthritis, osteoarthritis,
      osteoporosis, gout and juvenile idiopathic arthritis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2009</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>N/A</study_design>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Quality of the treatment of rheumatoid arthritis and other diseases</measure>
    <time_frame>Up to a year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Submission to federal reporting programs</measure>
    <time_frame>Up to a year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">820</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Rheumatology patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Rheumatoid Arthritis

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Melissa Francisco</last_name>
    <phone>404-633-3777</phone>
    <phone_ext>102</phone_ext>
    <email>mfrancisco@rheumatology.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rachel Myslinski</last_name>
    <phone>404-633-3777</phone>
    <phone_ext>824</phone_ext>
    <email>rmyslinski@rheumatology.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Registry Site</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30319</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Francisco</last_name>
      <phone>404-633-3777</phone>
      <phone_ext>102</phone_ext>
      <email>mfrancisco@rheumatology.org</email>
    </contact>
    <contact_backup>
      <last_name>Rachel Myslinski</last_name>
      <phone>404-633-3777</phone>
      <phone_ext>824</phone_ext>
      <email>rmyslinski@rheumatology.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 18, 2013</lastchanged_date>
  <firstreceived_date>March 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
